Skip to Content

Viral Clearance Market Is Anticipated To Witness High Growth Owing To Stringent Regulations For Biologics Development

The Viral Clearance Market comprises products and services employed for viral removal or inactivation processes during manufacturing of biopharmaceuticals and vaccines. Viral clearance helps ensure safety of biologics by removing potential contaminants such as viruses, which is crucial as even trace amounts could cause severe adverse effects. The need for viral clearance arises from the fact that cell biology used in biologics production may harbor unknown or adventitious viruses. Moreover, regulations require comprehensive characterization and removal of potential viral impurities. This has boosted adoption of viral clearance assays and services.


The Viral Clearance Market is estimated to be valued at US$ 0.9 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024-2031.


Key Takeaways

Key players operating in the Viral Clearance Market are Charles River Laboratories, Creative Biolabs, Eurofins Scientific, Microbac Laboratories, and MilliporeSigma, among others. 


The market provides lucrative growth opportunities through development of new platforms that can reduce turnaround time as well as provide scalable solutions. Emerging techniques such as high-throughput sequencing and microchip electrophoresis offer potential but require further validation.


Globally, viral clearance product adoption is expanding across major pharmaceutical manufacturing hubs. However, Asia Pacific is seeing fastest gains aided by increasing biologics production in China, India, and South Korea to meet regional demand. Contract service providers are also establishing facilities in these countries.


Market Drivers

 

 


Market restraints


High cost of assays: Established and emerging viral clearance techniques have substantial capital and operational costs, which could impact uptake, especially for biosimilars and generic manufacturers.


Need for assay optimization: Further improvements are still required for some newer methods to achieve quantitative detection at low concentrations and scalable solutions compatible with high-throughput screening. This may hinder complete adoption.


Segment Analysis

The Viral Clearance Market is segmented based on application, method, end user, and geography. By application, the market is divided into biologicals, medical devices, water purification, and others. Among these, the biologicals segment accounted for the largest market share in 2024 owing to the rising demand for monoclonal antibodies and recombinant proteins. Based on method, the market is bifurcated into viral detection, viral removal, and viral inactivation. Among these, viral removal segment dominated the market in 2024 due high demand for chromatography and nanofiltration techniques for removal of viruses from different biologics. Geographically, the Viral Clearance Market is studied across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.


Global Analysis

On regional front, North America held the largest share of Viral Clearance Market in 2024 due to rising demand for monoclonal antibodies and recombinant products coupled with presence of robust pharmaceutical and biotechnology industries in the region. However, Asia Pacific is expected to witness the highest growth during the forecast period owing to rising awareness regarding biosafety, increasing investments in biologics sector, and growing incidence of infectious diseases. Some of the key players operating in the Viral Clearance Market include Charles River Laboratories, Creative Biolabs, Eurofins Scientific, Microbac Laboratories, and MilliporeSigma among others. These players are focusing on new product launches, mergers, acquisitions, and collaborations to strengthen their global presence.

Get more insights on this topic: https://www.dailyprbulletin.com/viral-clearance-market-is-growing-driven-by-stringent-regulations/

 

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

 

What Are The Key Data Covered In This Viral Clearance Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Viral Clearance's growth between 2024 and 2031.

:- Accurate calculation of the size of the Viral Clearance and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Viral Clearance Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Viral Clearance vendors

FAQ’s

Q.1 What are the main factors influencing the Viral Clearance?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Viral Clearance companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Viral Clearance’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:

1. Source: Coherent Market Insights, Public sources, Desk research

2. We have leveraged AI tools to mine information and compile it

in News
RNA Therapeutics Market Poised To Grow At A Stellar CAGR Of 68% During 2024-2031